Natural Born Healers

22/01/2026

Jacks making my TikTok…. Watch this space

19/01/2026

Enrol Now for February/March 2026 – Start Your Journey in the Cannabis & H**p Industry!

We are excited to open enrolments for the 2026 intake of our National Certificate in Plant Production: Cannabis & H**p (NQF Level 4) offered with Cheeba Cannabis & H**p Academy and AgriColleges International.

This one-year online course covers:
✔️ Farm Management & Agribusiness
✔️ Licensing & Compliance
✔️ Good Agricultural Practices
✔️ Cannabis & H**p Production
✔️ Plus a 5-day practical at a SAHPRA-licensed farm in Gauteng

Open to applicants aged 18+ with Grade 10
AgriSETA Accredited
Turn your interest into a qualification and a career!

Enrol now for 2026: https://cheebaafrica.com/pages/academy-national-certificate-in-plant-production-ca

**pFarming

19/01/2026

19/01/2026

This photo (altered using AI) was taken outside No.10, but the fight it represents happens every single day.

I didn’t choose to become an advocate.
I became one because my son needs medicine that works, and because the system still makes parents like me fight for it.

A former MP spoke about my family in Parliament. Not as politics, but as evidence of a system that, over seven years after the law changed, still denies children life-saving medication and pushes families to breaking point, emotionally and financially.

That wasn’t debate.
That was our reality.

I hold this sign for my son.
For every child denied the treatment that helps them live.
For every parent forced to be strong when they are exhausted.

I smile because I have to.
I keep going because I must.
And I will never give up, not until no parent has to fight like this again.

03/01/2026

A recent Brazilian clinical trial, published in the Journal of Alzheimer’s Disease and widely reported in December 2025, marks a groundbreaking development in exploring cannabis for Alzheimer’s treatment.

Researchers at the Federal University of Latin American Integration conducted a phase 2, randomized, double-blind, placebo-controlled study involving elderly patients aged 60-80 with mild Alzheimer’s disease.

Building on prior animal studies showing low-dose THC restoring cognition in aged mice and a 2022 case report where microdosing improved symptoms in one patient over 22 months, this trial tested daily oral microdoses of a balanced cannabis extract containing approximately 0.3 mg THC and 0.3 mg CBD—far below psychoactive levels.

Over 24-26 weeks, the treatment group showed stabilized cognitive function, as measured by the Mini-Mental State Examination (MMSE), while the placebo group experienced typical decline.

This pausing of progression represents the first human trial evidence of microdosing cannabinoids potentially halting Alzheimer’s-related cognitive deterioration without significant side effects.

Described as unprecedented, the approach leverages the endocannabinoid system’s role in neuroprotection, which naturally diminishes with age. Though promising, the study’s small sample size and limited scope to certain cognitive metrics highlight the need for larger, longer trials to confirm efficacy and safety.

Current Alzheimer’s therapies offer minimal benefit and often severe side effects, making this low-risk cannabinoid option a hopeful avenue amid rising dementia cases globally.

11/12/2025

https://cannareporter.eu/en/2025/12/11/New-Zealand-eliminates-licensing-requirements-for-growing-industrial-h**p--simplifying-bureaucracy-so-the-h**p-sector-can-flourish--says-the-government./

Reading Time: 2 minutes. New Zealand is today taking a decisive step towards modernizing the legal framework for industrial h**p, with the Minister of Regulation announcing a profound reform that eliminates the need for mandatory licenses and reduces the bureaucratic burden imposed on producers. The...

10/12/2025

Many livestock farms are located in Oregon, and if this works, many of this livestock can be fed h**p biomass. The best way to repurpose the h**p industry...

10/12/2025

10/12/2025

For the fifth consecutive year, researchers worldwide have published over 4,000 scientific papers on cannabis, bringing the total number of published studies to more than 53,000, according to analysis by the non-profit advocacy group NORML.

Despite this growing body of research, NHS prescriptions remain severely limited as UK regulators say there isn’t sufficient evidence to prescribe it more widely on the NHS.

“It is time for politicians and others to stop assessing cannabis through the lens of ‘what we don’t know’ and instead start engaging in evidence-based discussions..." said NORML’s Deputy Director Paul Armentano.

Read more in the comments.

10/12/2025

Adaptogenic Mushrooms: Your Right to Natural Wellness is Under Threat!

17/10/2025